LogoThe Hemingway Report
Upgrade
Login
Subscribe

Archive

#42: Impact of Gen-AI tool on therapy outcomes

Mar 14, 2025

•

2 min read

#42: Impact of Gen-AI tool on therapy outcomes

plus two other interesting studies you should know about

Steve Duke
Steve Duke

THR Pro

Earnings Season: DTC Decline, Return of M&A + Financial and Valuation Benchmarks

Mar 7, 2025

•

2 min read

Earnings Season: DTC Decline, Return of M&A + Financial and Valuation Benchmarks

Talkspace, Lifestance, Teladoc and Acadia + what to expect in 2025

Steve Duke
Steve Duke
#40: The funding landsacpe, VBC insights + AI therapy (again)

Mar 1, 2025

•

1 min read

#40: The funding landsacpe, VBC insights + AI therapy (again)

plus the impact of the new US administration

Steve Duke
Steve Duke
#39: Transforming Traditional Mental Health Services

Feb 22, 2025

•

18 min read

#39: Transforming Traditional Mental Health Services

Founder Conversations with Isar Mazer of Tacklit

Steve Duke
Steve Duke
#38: Non-reimbursable mental health interventions

Feb 19, 2025

•

15 min read

#38: Non-reimbursable mental health interventions

what to do when the system won't pay for things that work

Steve Duke
Steve Duke
#37: Neuroflow buys Quartet + Talkspace at JPM

Feb 6, 2025

•

8 min read

#37: Neuroflow buys Quartet + Talkspace at JPM

My reaction to the Quartet sale, AI at Talkspace and capture rate for payer strategies

Steve Duke
Steve Duke
#36: A guide to unit economics in mental health (with OneMind)

Jan 30, 2025

•

17 min read

#36: A guide to unit economics in mental health (with OneMind)

Metrics to measure, common mistakes plus strategies to improve

Steve Duke
Steve Duke

THR Pro

#35: Will AI lead to the unbundling of therapy?

Jan 23, 2025

•

3 min read

#35: Will AI lead to the unbundling of therapy?

...and to what extent might it replace humans in mental health?

Steve Duke
Steve Duke
#34: Investor conversations with Dr. Pooja Sikka (GP at the Innovations in Mental Health Fund)

Jan 16, 2025

•

2 min read

#34: Investor conversations with Dr. Pooja Sikka (GP at the Innovations in Mental Health Fund)

Opportunities, founder advice, GTM insights, innovation trends and more

Steve Duke
Pooja Sikka
Steve Duke, +1
#33: Psychedelics in Mental Health - what you need to know (Part I)

Jan 9, 2025

•

4 min read

#33: Psychedelics in Mental Health - what you need to know (Part I)

An objective analysis of the state of psychedelic treatments in mental health

Steve Duke
Valentine Assal
Steve Duke, +1
THR Pro: The Mental Health Industry Leadership Report 2024

Dec 19, 2024

•

2 min read

THR Pro: The Mental Health Industry Leadership Report 2024

Insider insights on growth, profitability and the challenges of mental health businesses in 2024

Steve Duke
Steve Duke
#32: The top research and innovation trends of 2024

Dec 12, 2024

•

2 min read

#32: The top research and innovation trends of 2024

Biomarkers, drug breakthroughs, AI and more.

Steve Duke
Steve Duke
1...456789
The Hemingway Report

The Hemingway Report

The only weekly publication for mental health innovators.


Home

Account

© 2026 The Hemingway Report.
beehiivPowered by beehiiv